HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects.

Abstract
To determine circulating levels of adipocytokines, especially the recently characterized visfatin, and the fat-derived factor retinol-binding protein-4 (RBP-4) in HIV-infected subjects and their respective changes following treatment with highly active antiretroviral therapy (HAART). Fourteen HIV-positive, HAART-naïve subjects were compared with 10 HIV-negative healthy controls and reassessed after a 1-year treatment with HAART. Plasma visfatin and RBP-4 were determined by ELISA, whereas leptin and adiponectin by RIA. Body composition was measured with dual X-ray absorptiometry (DXA). Homeostasis model assessment (HOMA-IR) was assessed using insulin and glucose levels. Visfatin and RBP-4 levels in HIV-positive subjects were comparable with those of HIV-negative controls before treatment with HAART. Treatment with HAART for 12 months resulted in a 6.9-fold and 7.1-fold increase of visfatin and RBP-4 levels (+54.0 +/- 9.7 ng mL(-1), P < 0.0001 and +95.3 +/- 31.7 ng mL(-1), P < 0.01), respectively. Leptin (-2.7 +/- 1.6 ng mL(-1), P = 0.054) was unchanged and adiponectin (-2.8 +/- 0.7 microg mL(-1), P < 0.01) decreased. Changes of visfatin concentrations correlated significantly with the increases of RBP-4 (r = 0.78, P = 0.001), fat-free mass (FFM, r = 0.75, P < 0.05) and change of HOMA-IR (r = 0.64, P < 0.05). Parameters of glucose metabolism and body fat mass were unchanged during the observation period. Treatment with HAART induced a pronounced increase of plasma visfatin and RBP-4 as well as a decrease of adiponectin in HIV-infected patients on HAART. Although body weight, fat mass and parameters of glucose metabolism remained stable, the changes in the adipocytokines might herald subsequent alterations of these parameters.
AuthorsK Schindler, D Haider, M Wolzt, A Rieger, B Gmeinhart, A Luger, P Nowotny, B Ludvik
JournalEuropean journal of clinical investigation (Eur J Clin Invest) Vol. 36 Issue 9 Pg. 640-6 (Sep 2006) ISSN: 0014-2972 [Print] England
PMID16919047 (Publication Type: Journal Article)
Chemical References
  • Adiponectin
  • Cytokines
  • Insulin
  • Leptin
  • RBP4 protein, human
  • Retinol-Binding Proteins
  • Retinol-Binding Proteins, Plasma
  • Cholesterol
  • Nicotinamide Phosphoribosyltransferase
  • nicotinamide phosphoribosyltransferase, human
  • Glucose
Topics
  • Adiponectin (blood)
  • Adipose Tissue (physiology)
  • Adult
  • Antiretroviral Therapy, Highly Active (methods)
  • Body Composition (physiology)
  • Cholesterol (blood)
  • Cytokines (blood)
  • Female
  • Glucose (metabolism)
  • HIV Infections (blood, drug therapy)
  • HIV-1
  • Humans
  • Insulin (blood, metabolism)
  • Leptin (blood)
  • Male
  • Nicotinamide Phosphoribosyltransferase
  • Retinol-Binding Proteins (analysis)
  • Retinol-Binding Proteins, Plasma

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: